146 related articles for article (PubMed ID: 37728806)
1. Early diagnosis and prognostic potential of RAC3 in bladder tumor.
Wang S; Wei Z; Shu H; Xu Y; Fan Z; Shuang S; Li P; Lu P; Ye C
Int Urol Nephrol; 2024 Feb; 56(2):475-482. PubMed ID: 37728806
[TBL] [Abstract][Full Text] [Related]
2. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
[No Abstract] [Full Text] [Related]
3. Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
Zheng W; Zhang J; Song Q; Xu Y; Zhu M; Ma J
DNA Cell Biol; 2021 Mar; 40(3):469-481. PubMed ID: 33600260
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a prognostic model to predict chemotherapy response and identification of RAC3 as a chemotherapeutic target in bladder cancer.
Chen Y; Huang M; Lu J; Zhang Q; Wu J; Peng S; Chen S; Zhang Y; Cheng L; Lin T; Chen X; Huang J
Environ Toxicol; 2024 Feb; 39(2):509-528. PubMed ID: 37310098
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylated gene RAC3 induces cell proliferation and invasion by increasing FASN expression in endometrial cancer.
Meijuan C; Fang L; Min F; Qian W
Int J Biochem Cell Biol; 2022 Sep; 150():106274. PubMed ID: 35917927
[TBL] [Abstract][Full Text] [Related]
6. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y
Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of RAC3 in bladder cancer predicts adverse clinical outcome and increased tumor immune response.
Ou-Yang S; Liu JH; Wang QZ
Int J Clin Exp Pathol; 2020; 13(12):2937-2949. PubMed ID: 33425095
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of semaphorin 3A in patients with urothelial cancer.
Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis identifies RAC3 as an immune-related prognostic biomarker associated with chemotherapy sensitivity in endometrial cancer.
Huang P; Qian Y; Xia Y; Wang S; Xu C; Zhu X; Gao Q
J Cell Mol Med; 2023 Aug; 27(16):2385-2397. PubMed ID: 37386813
[TBL] [Abstract][Full Text] [Related]
10. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
[TBL] [Abstract][Full Text] [Related]
11. [Non-invasive urinary diagnosis of bladder cancer. What do we know?].
Kausch I; Böhle A
Urologe A; 2003 Jul; 42(7):912-21. PubMed ID: 12898034
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75.
Cai T; Feng T; Li G; Wang J; Jin S; Ye D; Zhu Y
Cancer Cell Int; 2024 Apr; 24(1):125. PubMed ID: 38570787
[TBL] [Abstract][Full Text] [Related]
13. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer.
Urquidi V; Goodison S; Ross S; Chang M; Dai Y; Rosser CJ
J Urol; 2012 Dec; 188(6):2377-83. PubMed ID: 23088986
[TBL] [Abstract][Full Text] [Related]
15. Rac3 regulates cell proliferation through cell cycle pathway and predicts prognosis in lung adenocarcinoma.
Wang G; Wang H; Zhang C; Liu T; Li Q; Lin X; Xie J; Liu H
Tumour Biol; 2016 Sep; 37(9):12597-12607. PubMed ID: 27402308
[TBL] [Abstract][Full Text] [Related]
16. BLCA-4 and UBC combined detection for early diagnosis of bladder cancer.
Cui L; Sun MM; Zhao ZH; Yang JP; Zheng YP; He LL; Chen KS; Fan QX
J Biol Regul Homeost Agents; 2016; 30(2):485-90. PubMed ID: 27358136
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of urine N1,N12-Diacetylspermine as potential tumor marker for urinary bladder cancer.
Stejskal D; Humenanska V; Hanulova Z; Fiala R; Vrtal R; Solichova P; Karpisek M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):235-7. PubMed ID: 17426784
[TBL] [Abstract][Full Text] [Related]
18. High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer.
Yang L; Li YL; Li XQ; Zhang Z
Dis Markers; 2019; 2019():4586405. PubMed ID: 30984306
[TBL] [Abstract][Full Text] [Related]
19. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
[TBL] [Abstract][Full Text] [Related]
20. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.
Datta A; Adelson ME; Mogilevkin Y; Mordechai E; Sidi AA; Trama JP
BMC Cancer; 2011 Jun; 11():234. PubMed ID: 21663673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
